Antibiotic Myths for the Infectious Diseases Clinician
- PMID: 37310038
- DOI: 10.1093/cid/ciad357
Antibiotic Myths for the Infectious Diseases Clinician
Erratum in
-
Correction to: Antibiotic Myths for the Infectious Diseases Clinician.Clin Infect Dis. 2024 Jun 14;78(6):1780. doi: 10.1093/cid/ciae161. Clin Infect Dis. 2024. PMID: 38669212 No abstract available.
Abstract
Antimicrobials are commonly prescribed and often misunderstood. With more than 50% of hospitalized patients receiving an antimicrobial agent at any point in time, judicious and optimal use of these drugs is paramount to advancing patient care. This narrative will focus on myths relevant to nuanced consultation from infectious diseases specialists, particularly surrounding specific considerations for a variety of antibiotics.
Keywords: cefazolin; clindamycin; linezolid; trimethoprim-sulfamethoxazole.
© The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Conflict of interest statement
Potential conflicts of interest. The authors: No reported conflicts of interest. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest.
Comment in
-
Cefazolin for the Treatment of Central Nervous System Infections.Clin Infect Dis. 2024 Feb 17;78(2):489-490. doi: 10.1093/cid/ciad559. Clin Infect Dis. 2024. PMID: 37724584 No abstract available.
-
Central Nervous System Infections and Antibiotic Selection: All Infection Sites Are Not Created Equal.Clin Infect Dis. 2024 Aug 16;79(2):573-574. doi: 10.1093/cid/ciad772. Clin Infect Dis. 2024. PMID: 38113485 No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical